drug
varicella zoster vaccine
Marketedupdated 3mo agoby GlaxoSmithKline LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying varicella zoster vaccine
- phase2Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
- phase2A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
- phase2A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
- phase4Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
- phase3Shingrix in Renal Transplant Recipients
- phase1A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
- phase2Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
- phase2A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
News(1)
- STAT+: Shingles vaccine may lower dementia risk, new study findsNursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.stat · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that